利奈唑胺治疗结核性脑膜炎的疗效：一项荟萃分析。
Efficacy of linezolid in the treatment of tuberculous meningitis: a meta-analysis.
作者信息
Liu Xiaoshu, Tang Daoyan, Qi Min, He Jian-Qing
机构信息
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Department of Respiratory and Critical Care Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
出版信息
Arch Med Sci. 2024 Jun 29;20(3):1038-1042. doi: 10.5114/aoms/189905. eCollection 2024.
INTRODUCTION
Tuberculous meningitis (TBM) is a severe extra-pulmonary tuberculosis with high fatality. This meta-analysis aimed to assess the impact of linezolid on TBM treatment outcomes.
METHODS
We searched multiple databases for studies published up to May 18, 2024 comparing the effects of linezolid on TBM. Meta-analysis was conducted using Review Manager 5.4.
RESULTS
Our findings indicated that linezolid may reduce treatment failure risk (RR = 0.42 (0.20, 0.89), = 0.02) and improve temperature recovery (RR = 1.56 (1.21, 2.02), < 0.001) in TBM patients.
CONCLUSIONS
The analysis suggests a positive association between linezolid treatment and therapeutic improvements, with no significant adverse reactions reported.
引言
结核性脑膜炎（TBM）是一种严重的肺外结核病，病死率很高。本荟萃分析旨在评估利奈唑胺对TBM治疗结果的影响。
方法
我们检索了多个数据库，以查找截至2024年5月18日发表的比较利奈唑胺对TBM影响的研究。使用Review Manager 5.4进行荟萃分析。
结果
我们的研究结果表明，利奈唑胺可能会降低TBM患者的治疗失败风险（RR = 0.42（0.20，0.89），P = 0.02）并改善体温恢复情况（RR = 1.56（1.21，2.02），P < 0.001）。
结论
分析表明利奈唑胺治疗与治疗改善之间存在正相关，且未报告有明显不良反应。
Zotero 插件